Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Completed

Conditions studied: Coronary Artery Disease

In brief

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Key facts

Study ID

NCT01134159

Run by

Medstar Health Research Institute

People needed

1200

Starts

2010-06-01

Expected to finish

2010-09-01

Last updated by the study team

2011-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older, both genders
• Underwent PCI with Taxus Liberte (alone) or Xience (alone)

You may not qualify if…

• Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure
• Received both Taxus-Liberte and Xience-V during the same index procedure
• Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Where it is running

• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Midwest Cardiovascular Research Foundation — Davenport, Iowa, United States
• Iowa Heart Center — West Des Moines, Iowa, United States
• Maine Medical Center — Portland, Maine, United States
• Washington Adventist Hospital — Takoma Park, Maryland, United States
• Genesys Regional Medical Center — Grand Blanc, Michigan, United States
• Oklahoma Foundation for Cardiovascular Research — Oklahoma City, Oklahoma, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Grand Strand Regional Medical Center — Myrtle Beach, South Carolina, United States
• Heart Clinics Northwest — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.